News and Press Releases

Ascelia Pharma Successfully Meets Primary Endpoint with Strong Headline Results in Orviglance Phase 3 Study

2 May 2023 -- Malmö, Sweden -- Ascelia Pharma, a biotech focused on improving the life of people living with rare cancer conditions, today announced that liver imaging drug candidate,...

Category: Biotechnology, Pharmaceutical
Posted: May 2, 2024

Hyllie Stationstorg 31 215 32 Malmö